← LEMAITRE VASCULAR INC LMAT
Market Price
$82.40
Market Cap
$1.87B
P/E Ratio
32.70
Revenue (FY 2025)
↑13.5% YoY
$249.60M
3-Yr CAGR: 15.6%
Net Income
↑31.1% YoY
$57.73M
Net Margin: 23.1%
Free Cash Flow
↑100.4% YoY
$74.47M
FCF Yield: 3.98%
EPS (Diluted)
↑30.6% YoY
$2.52
Basic: $2.55
Return on Equity
Efficiency
14.7%
ROA: 1,136.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (LMAT)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $89.2M | — | $62.9M | $10.6M | — | $0.55 | — | $16.9M | $14.1M | — |
| FY 2017 | $100.9M | +13.1% | $70.7M | $17.2M | +62.2% | $0.86 | +56.4% | $22.9M | $16.5M | +17.0% |
| FY 2018 | $105.6M | +4.7% | $73.9M | $22.9M | +33.6% | $1.13 | +31.4% | $19.5M | $16.5M | +0.0% |
| FY 2019 | $117.2M | +11.0% | $79.9M | $17.9M | -21.8% | $0.88 | -22.1% | $14.2M | $10.4M | -36.7% |
| FY 2020 | $129.4M | +10.4% | $84.6M | $21.2M | +18.3% | $1.04 | +18.2% | $34.8M | $31.8M | +205.4% |
| FY 2021 | $154.4M | +19.4% | $101.4M | $26.9M | +26.8% | $1.25 | +20.2% | $35.1M | $30.2M | -5.0% |
| FY 2022 | $161.7M | +4.7% | $104.9M | $20.6M | -23.3% | $0.93 | -25.6% | $25.4M | $22.1M | -26.7% |
| FY 2023 | $193.5M | +19.7% | $127.0M | $30.1M | +45.9% | $1.34 | +44.1% | $36.8M | $29.5M | +33.1% |
| FY 2024 | $219.9M | +13.6% | $150.9M | $44.0M | +46.3% | $1.93 | +44.0% | $44.1M | $37.2M | +26.0% |
| FY 2025 | $249.6M | +13.5% | $178.5M | $57.7M | +31.1% | $2.52 | +30.6% | $81.3M | $74.5M | +100.4% |
Valuation
Market Price
$82.40
Market Cap
$1.87B
Enterprise Value
N/A
P/E Ratio
32.70
P/B Ratio
4.78
FCF Yield
3.98%
Dividend Yield
0.97%
Shares Outstanding
Profitability & Margins
Gross Margin
71.53%
Operating Margin
27.21%
Net Margin
23.13%
Return on Equity (ROE)
14.67%
Return on Assets (ROA)
1,136.50%
Asset Turnover
49.13x
Revenue 3-Yr CAGR
15.58%
Financial Health & Liquidity
Current Ratio
0.17
Cash Ratio
0.96
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$28.24M
Total Debt
N/A
Book Value / Share
$17.22
Cash Flow Efficiency
Operating Cash Flow
$81.25M
Capital Expenditures (CapEx)
$6.78M
Free Cash Flow
$74.47M
OCF / Revenue
32.55%
FCF / Revenue
29.83%
FCF 3-Yr CAGR
49.81%
Per Share Metrics
EPS (Diluted)
$2.52
EPS (Basic)
$2.55
Dividends / Share
$0.80
Book Value / Share
$17.22
EPS YoY Growth
30.57%
Balance Sheet (FY 2025)
Total Assets
$5.08M
Total Liabilities
$29.41M
Stockholders' Equity
$393.52M
Current Assets
$5.08M
Current Liabilities
$29.41M